2012
DOI: 10.1097/mol.0b013e3283513594
|View full text |Cite
|
Sign up to set email alerts
|

Atherosclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…PON1 null mice by gene targeting [12, 13] and transgenic mice [14] corroborate the hypothesis that PON1 protects against atherogenesis and is an important contributor to HDL's antioxidant capacity. The in vivo studies combined with the antioxidant and antiatherogenic nature of PON1 underscore the potential of PON1 as a therapeutic agent to prevent atheroma [20, 21]. The association of PON1 with HDL and its functional consequences support a causal relationship between PON1 and cardiovascular and its associated inflammatory pathologies [2226].…”
Section: 1 Introductionmentioning
confidence: 99%
“…PON1 null mice by gene targeting [12, 13] and transgenic mice [14] corroborate the hypothesis that PON1 protects against atherogenesis and is an important contributor to HDL's antioxidant capacity. The in vivo studies combined with the antioxidant and antiatherogenic nature of PON1 underscore the potential of PON1 as a therapeutic agent to prevent atheroma [20, 21]. The association of PON1 with HDL and its functional consequences support a causal relationship between PON1 and cardiovascular and its associated inflammatory pathologies [2226].…”
Section: 1 Introductionmentioning
confidence: 99%